MB DNA Studija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
116,787 |
116,787 |
4,597 |
4,346 |
4,346 |
42.73 |
3.72 |
12,141 |
49,120 |
2,008 |
59,253 |
2022 |
---|
168,109 |
168,109 |
-3,293 |
-3,612 |
-3,612 |
52.46 |
-2.15 |
8,529 |
130,523 |
23,383 |
115,669 |
2023 |
---|
134,150 |
- |
-1,176 |
-1,181 |
- |
45.30 |
-0.88 |
7,348 |
76,882 |
21,046 |
63,184 |
Register and
explore Okredo data2023 |
---|
134,150 |
- |
-1,176 |
-1,181 |
- |
45.30 |
-0.88 |
7,348 |
76,882 |
21,046 |
63,184 |
Register and
explore Okredo data2023
Turnover (€)
134,150 €-20 % *
Sales per employee (€)
-Profit before tax (€)
-1,176 €64 % *
Net Profit (€)
-1,181 €67 % *
Profit per employee (€)
-Total profitability (%)
45.30 %-13.65 % *
Net profitability (%)
-0.88 %59.07 % *
Equity (€)
7,348 €-14 % *
Amounts Payable And Liabilities (€)
76,882 €-41 % *
Non-current Assets (€)
21,046 €-10 % *
CurrentAssets (€)
63,184 €-45 % *